EDP-788 / Enanta Pharma - LARVOL DELTA

Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788 (clinicaltrials.gov) - P1; N=64; Recruiting; Sponsor: Enanta Pharmaceuticals; Not yet recruiting -> Recruiting ; Trial primary completion date: Jun 2014 ->Sep 2014

Enrollment open • Trial primary completion date • Biosimilar